Advances in MRI diagnosis of cirrhosis and hepatocellular

Most of the cirrhosis and hepatic carcinoma patients have reached an advanced stage as they are diagnosed, the prognosis is poor, and its early diagnosis and treatment are essential for the patient's prognosis. With medical diagnostic imaging technology advanced, more and more MRI technology is used to the diagnosis, such as diffusion-weighted imaging, perfusion-weighted imaging, new hepatocellular specific contrast agent enhanced MRI can provide more extensive diagnostic information from a plurality of the molecular level, cellular functions, and improve the accuracy of diagnosis of cirrhosis and hepatic carcinoma. This is of great significance to improve cirrhosis and hepatic carcinoma's diagnostic accuracy and improve patient's prognosis.